N4 Pharma EPO has now formally granted European Patent - DirectorsTalk Interviews
N4 Pharma EPO has now formally granted European Patent
Stay updated with breaking news from Pharma Plc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
N4 Pharma EPO has now formally granted European Patent
N4 Pharma Plc Regulatory News. Live N4P RNS. Regulatory News Articles for N4 Pharma Plc Ord 0.4P
/PRNewswire/ -- The human microbiome therapeutics market will grow by USD 516.08 million from 2021 to 2025, while registering a CAGR of 47.79%, as per...
Herantis Pharma Plc Company Release August 26, 2021, at 9:00 a.m. EEST/8:00 a.m. CEST Dr. Craig Cook CEO of Herantis commented: In 2021, Herantis continued to optimize its assets and shape the... | August 27, 2021
- Net assets per share 6.24 pence at 31 March 2021 (2020: 2.50 pence). - Profit after tax of £3.09 million (2020: loss £0.30 million). - Investments at 31 March 2021 valued at £5.11 million (2020: £1.18 million). - Spend on new investments of £1.90 million (2020: £1.38 million). - Investment realisation proceeds of £1.21 million (2020: £2.03 million). - Cash at 31 March 2021 of £0.05 million (2020: £0.90 million). - Post year end raised...